This symposium explores how dermatology pathways are transforming through smarter use of data, value-based decision‑making, and the evolving role of pharmacists. Speakers will examine national NHS drivers, pathway analysis, and biologic optimisation, highlighting how pharmacists can influence prescribing, reduce variation, and enhance service efficiency. The session will also address implementation challenges, workforce alignment, and future opportunities including national formulary developments.

Almirall has no input to the meeting contents, agenda, and other arrangements and Almirall’s involvement is limited to making a defined financial contribution.

UK&IE-NOP-2600042 | Date of prep: April 2026